These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18084768)

  • 21. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of ultrasound-targeted vascular endothelial growth factor receptor-2 in non-invasive monitoring of anti-angiogenic response in nude mice with subcutaneous xenograft model].
    Wang L; Lu YH; Wang TY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):856-860. PubMed ID: 33113627
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of tumor vasculature distributions in central and peripheral regions based on Doppler ultrasound.
    Chen JJ; Fu SY; Chiang CS; Hong JH; Yeh CK
    Med Phys; 2012 Dec; 39(12):7490-8. PubMed ID: 23231298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of quantified contrast-enhanced sonography with in vivo tumor response.
    Hwang M; Hariri G; Lyshchik A; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2010 Apr; 29(4):597-607. PubMed ID: 20375378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
    Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
    Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of angiogenesis: implications for ultrasound imaging.
    Forsberg F; Ro RJ; Potoczek M; Liu JB; Merritt CR; James KM; Dicker AP; Nazarian LN
    Ultrasonics; 2004 Apr; 42(1-9):325-30. PubMed ID: 15047306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
    Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
    Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
    Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
    Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging.
    Zwick S; Strecker R; Kiselev V; Gall P; Huppert J; Palmowski M; Lederle W; Woenne EC; Hengerer A; Taupitz M; Semmler W; Kiessling F
    J Magn Reson Imaging; 2009 May; 29(5):1125-33. PubMed ID: 19388117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound.
    Palmowski M; Lederle W; Gaetjens J; Socher M; Hauff P; Bzyl J; Semmler W; Günther RW; Kiessling F
    Eur J Radiol; 2010 Jul; 75(1):e149-53. PubMed ID: 19945241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
    Rössler J; Monnet Y; Farace F; Opolon P; Daudigeos-Dubus E; Bourredjem A; Vassal G; Geoerger B
    Int J Cancer; 2011 Jun; 128(11):2748-58. PubMed ID: 20715103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of molecular imaging on validation of developed anti-hVEGFR2 therapeutic antibody.
    Cheong SJ; Lee CM; Jang D; Kim EM; Jeong MH; Uhm TB; Lee WS; Jeong HJ; Kim DW; Lim ST; Sohn MH
    Cancer Biother Radiopharm; 2011 Dec; 26(6):745-51. PubMed ID: 22003972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
    Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
    Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow.
    Goertz DE; Yu JL; Kerbel RS; Burns PN; Foster FS
    Cancer Res; 2002 Nov; 62(22):6371-5. PubMed ID: 12438217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
    Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
    Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies.
    Cheung AM; Brown AS; Cucevic V; Roy M; Needles A; Yang V; Hicklin DJ; Kerbel RS; Foster FS
    Ultrasound Med Biol; 2007 Aug; 33(8):1259-68. PubMed ID: 17467156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.